Bohao Zheng

1.8k total citations
53 papers, 1.3k citations indexed

About

Bohao Zheng is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Bohao Zheng has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Bohao Zheng's work include Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bohao Zheng is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bohao Zheng collaborates with scholars based in China, United States and United Kingdom. Bohao Zheng's co-authors include Qiang Gao, Jiaqiang Ma, Liangqing Dong, Shengtao Zhou, Meng Duan, Jia Fan, Shyamal Goswami, Zhao Zhang, Lijie Ma and Xiaoming Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Bohao Zheng

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bohao Zheng China 19 520 422 378 333 248 53 1.3k
Qihan Fu China 21 664 1.3× 629 1.5× 371 1.0× 518 1.6× 161 0.6× 44 1.5k
Liangrong Shi China 17 663 1.3× 255 0.6× 544 1.4× 180 0.5× 107 0.4× 33 1.2k
Antonella Argentiero Italy 23 794 1.5× 596 1.4× 406 1.1× 427 1.3× 140 0.6× 48 1.6k
Moo Jun Baek South Korea 20 492 0.9× 532 1.3× 174 0.5× 245 0.7× 147 0.6× 87 1.3k
Jianming Zheng China 22 517 1.0× 912 2.2× 279 0.7× 664 2.0× 160 0.6× 59 1.7k
Huaxiang Xu China 23 1.0k 1.9× 735 1.7× 662 1.8× 477 1.4× 173 0.7× 54 2.1k
Jingjing Zhao China 18 594 1.1× 378 0.9× 287 0.8× 214 0.6× 98 0.4× 72 1.2k
Cheng Zhou China 17 250 0.5× 583 1.4× 179 0.5× 436 1.3× 116 0.5× 51 1.1k
R. K. Jain India 11 557 1.1× 525 1.2× 190 0.5× 226 0.7× 238 1.0× 30 1.2k
Weiheng Zhao China 16 1.1k 2.1× 723 1.7× 478 1.3× 288 0.9× 136 0.5× 29 1.9k

Countries citing papers authored by Bohao Zheng

Since Specialization
Citations

This map shows the geographic impact of Bohao Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bohao Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bohao Zheng more than expected).

Fields of papers citing papers by Bohao Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bohao Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bohao Zheng. The network helps show where Bohao Zheng may publish in the future.

Co-authorship network of co-authors of Bohao Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Bohao Zheng. A scholar is included among the top collaborators of Bohao Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bohao Zheng. Bohao Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Yang, et al.. (2025). Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies. Oncogene. 44(7). 409–426. 2 indexed citations
3.
4.
Zhang, Haiying, et al.. (2024). Ginsenoside RK3 inhibits glioblastoma by modulating macrophage M2 polarization via the PPARG/CCL2 axis. Phytomedicine. 136. 156271–156271. 4 indexed citations
5.
Sheng, Rubin, Bohao Zheng, Yanping Zhang, et al.. (2024). “Very early” intrahepatic cholangiocarcinoma (≤ 2.0 cm): MRI manifestation and prognostic potential. Clinical Radiology. 79(8). 608–617. 1 indexed citations
6.
Huang, Fuqiang, Na Zhao, Pei Cai, et al.. (2024). Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer. Translational research. 268. 51–62. 7 indexed citations
8.
Wang, Xu, et al.. (2023). Understanding endometriosis from an immunomicroenvironmental perspective. Chinese Medical Journal. 136(16). 1897–1909. 18 indexed citations
9.
Zan, Rui, Sheng Shen, Yuanding Huang, et al.. (2023). Research hotspots and trends of biodegradable magnesium and its alloys. SHILAP Revista de lepidopterología. 4. 468–479. 25 indexed citations
10.
Ma, Jiaqiang, Kai Zhu, Lei Yu, et al.. (2023). Spatial immunophenotypes predict clinical outcome in intrahepatic cholangiocarcinoma. JHEP Reports. 5(8). 100762–100762. 11 indexed citations
11.
Fan, Kun, Jiwen Wang, Sheng Shen, et al.. (2022). ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth. Medical Oncology. 39(6). 64–64. 2 indexed citations
12.
Fan, Kun, Xiaojian Ni, Sheng Shen, et al.. (2022). Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis. Cell Death Discovery. 8(1). 265–265. 4 indexed citations
13.
Zheng, Bohao, Sheng Shen, Kwong‐Fai Wong, et al.. (2021). Clinical correlation of cadherin‐17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma. Journal of Surgical Oncology. 123(5). 1253–1262. 9 indexed citations
14.
Li, Min, Kun Fan, Bohao Zheng, et al.. (2021). Knockdown of SLC39A4 Expression Inhibits the Proliferation and Motility of Gallbladder Cancer Cells and Tumor Formation in Nude Mice. Cancer Management and Research. Volume 13. 2235–2246. 7 indexed citations
15.
Liang, Yan, et al.. (2020). Protective Effects of Crocetin on Arsenic Trioxide-Induced Hepatic Injury: Involvement of Suppression in Oxidative Stress and Inflammation Through Activation of Nrf2 Signaling Pathway in Rats. SHILAP Revista de lepidopterología. 3 indexed citations
16.
Yang, Chunrui, Li Ning, Fiona H. Zhou, et al.. (2020). Downregulation of Adhesion Molecule CHL1 in B Cells but Not T Cells of Patients with Major Depression and in the Brain of Mice with Chronic Stress. Neurotoxicity Research. 38(4). 914–928. 12 indexed citations
17.
Fan, Kun, Jiwen Wang, Wentao Sun, et al.. (2020). MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth. Experimental Cell Research. 394(1). 112118–112118. 27 indexed citations
18.
Shen, Sheng, Dexiang Zhang, Bohao Zheng, et al.. (2019). DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN. Bioscience Biotechnology and Biochemistry. 83(12). 2257–2264. 14 indexed citations
19.
Zheng, Bohao, Liu‐Xiao Yang, Qi‐Man Sun, et al.. (2017). A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma. Clinical and Translational Gastroenterology. 8(10). e118–e118. 28 indexed citations
20.
Zhang, Xuesong, Baohui Han, Jia Huang, et al.. (2010). Prognostic Significance of OCT4 Expression in Adenocarcinoma of the Lung. Japanese Journal of Clinical Oncology. 40(10). 961–966. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026